PCI Pharma Services has become the first contract development and manufacturing organization (CDMO) to successfully navigate the International Coalition of Medicines Regulatory Authorities (ICMRA) inspection process under its new Collaborative Hybrid Inspection Pilot (CHIP) program. The inspection took place at
Life Molecular Imaging (LMI) and PharmaLogic Holdings Corp. have announced a strategic partnership and licensing agreement to distribute Neuraceq® from PharmaLogic’s radiopharmaceutical manufacturing site near Denver, Colorado. The collaboration aims to enhance the availability of this FDA-approved imaging agent used
ST Pharm and Quantoom Biosciences have announced an extended collaboration to advance the development and manufacturing of RNA-based vaccines and therapeutics. This partnership integrates the complementary strengths of both companies to enhance the global supply of critical RNA manufacturing technologies.
VGXI, Inc., a CDMO specialising in nucleic acid biopharmaceuticals, has announced its acceptance into the Biopharmaceutical Manufacturing Preparedness (BioMap) Consortium. This consortium, supported by the Biomedical Advanced Research and Development Authority (BARDA), aims to strengthen the United States’ biopharmaceutical manufacturing
Bora Pharmaceuticals Co. Ltd. has completed the acquisition of Emergent BioSolutions’ sterile manufacturing facility located in Baltimore-Camden, Maryland. This acquisition expands Bora’s capabilities in drug product manufacturing, particularly in the area of sterile injectables, adding to its existing biologics drug
FUJIFILM Diosynth Biotechnologies has officially opened its expanded microbial fermentation manufacturing facility in Billingham, UK, following a £100 million investment. The new facility, which triples the company’s microbial production capacity, includes 2 X 4,000-litre fermenters, a primary separations suite, and
Terumo BCT and Charles River Laboratories have released data showcasing the adaptability of Terumo BCT’s Finia automated fill and finish system in various cell and gene therapy (CGT) workflows. The Finia platform, designed to optimize the cooling, aliquoting, and packaging
Exclusive event for senior drug development leaders. 19th May 2026 at CDMO Live
Exclusive event for senior external manufacturing leaders. 26th May 2026 at CDMO Live
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. has officially introduced its “oneClick+” platform, designed to enhance antibody development efficiency. This new platform integrates 90% of the mainstream antibody structures currently available, facilitating the design of various antibody configurations. Launched recently, the “oneClick+”
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
